Helius Medical Technologies Announces Authorization from Health Canada to Market the PoNS(TM) Device for the Treatment of Gait Deficit Due to Mild and Moderate Multiple Sclerosis (MS)

Stock Information for Helius Medical Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.